Liquid-crystalline medium

US11214736B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11214736-B2
Application numberUS-201615512940-A
CountryUS
Kind codeB2
Filing dateSep 8, 2016
Priority dateSep 9, 2015
Publication dateJan 4, 2022
Grant dateJan 4, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compounds of the formula I, liquid-crystalline media which contain at least one compound of the formula I and electro-optical displays which contain the LC mixtures, especially for the self-aligning VA, PSA, PS-VA, PVA, MVA, PM-VA, HT-VA or VA-IPS modein which R1, R2, ring A1, Z1, Z2, Sp, P, L1, L2, r1, r2, r3, m, n, p1 and p2 have the meanings indicated above.

First claim

Opening claim text (preview).

The invention claimed is: 1. Liquid-crystalline medium based on a mixture of polar compounds which contains at least one compound of the formula I, in which R 1 denotes H, an alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH 2 groups in these radicals may each be replaced, independently of one another, by —CH═CH—, —C≡C—, —CF 2 O—, —CH═CH—, —O—, —CO—O—, —O—CO— in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen, R 2 denotes an alkyl radical having 1 to 8 C atoms, Denotes L 1 and L 2 in each case, independently of one another, denotes F, Cl, Br, I, —CN, —NO 2 , —NCO, —NCS, —OCN, —SCN, straight-chain alkyl having 1 to 5 C atoms, branched alkyl having 3 to 5 C atoms, alkoxy having 1 to 5 C atoms, alkylcarbonyl having 2 to 5 C atoms, alkoxycarbonyl having 2 to 5 C atoms, in which, in addition, one or more H atoms may be replaced by F or Cl, L 3 in each case, independently of one another, denotes Cl, Br, I, —CN, —NO 2 , —NCO, —NCS, —OCN, —SCN, straight-chain alkyl having 1 to 5 C atoms, branched alkyl having 3 to 5 C atoms, alkoxy having 1 to 5 C atoms, alkylcarbonyl having 2 to 5 C atoms, alkoxycarbonyl having 2 to 5 C atoms, alkylcarbonyloxy having 2 to 5 C atoms or alkoxycarbonyloxy having 2 to 5 C atoms, in which, in addition, one or more H atoms may be replaced by F or Cl, m denotes 0, 1 or 2, n denotes 1 or 2, P denotes a polymerisable group, Sp denotes a spacer group or a single bond, Z 1 and Z 2 in each case, independently of one another, denotes a single bond, —O—, —S—, —CO—, —CO—O—, —OCO—, —O—CO—O—, —OCH 2 —, —CH 2 —, —CH 2 O—, —CF 2 O—, —OCF 2 —, —CH 2 CH 2 —, —(CH 2 ) 4 —, —CF 2 CH 2 —, —CH 2 CF 2 —, —CF 2 CF 2 —, —CH═CH—, —CF═CF—, —C≡C—, —CH═CH—COO— or —OCO—CH═CH—, p1 denotes 1, 2 or 3, r1 denotes 0, 1, 2 or 3, whereas p1+r1≤4, p2 denotes 0, 1, 2 or 3 r2 denotes 1, 2 or 3, whereas p2+r2≤4. 2. Liquid-crystalline medium according to claim 1 which contains at least one compound of the formula I*, in which R 1 denotes H, an alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH 2 groups in these radicals may each be replaced, independently of one another, by —CH═CH—, —C≡C—, —CF 2 O—, —CH═CH—, —O—, —CO—O—, —O—CO— in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen, R 2 denotes an alkyl radical having 1 to 8 C atoms, Denotes L 1 and L 2 in each case, independently of one another, denotes F, Cl, Br, I, —CN, —NO 2 , —NCO, —NCS, —OCN, —SCN, straight-chain alkyl having 1 to 5 C atoms, branched alkyl having 3 to 5 C atoms, alkoxy having 1 to 5 C atoms, alkylcarbonyl having 2 to 5 C atoms, alkoxycarbonyl having 2 to 5 C atoms, alkylcarbonyloxy having 2 to 5 C atoms or alkoxycarbonyloxy having 2 to 5 C atoms, in which, in addition, one or more H atoms may be replaced by F or Cl, P denotes a polymerisable group, Sp denotes a spacer group or a single bond, Z 1 and Z 2 in each case, independently of one another, denotes a single bond, —O—, —S—, —CO—, —CO—O—, —OCO—, —O—CO—O—, —OCH 2 —, —CH 2 —, —CH 2 O—, —CF 2 O—, —OCF 2 —, —CH 2 CH 2 —, —(CH 2 ) 4 —, —CF 2 CH 2 —, CH 2 CF 2 —, —CF 2 —CF 2 —, —CH═CH—, —CF═CF—, —C≡C—, —CH═CH—COO— or —OCO—CH═CH—, p1 denotes 1, 2 or 3, r1 denotes 0, 1, 2 or 3, whereas p1+r1≤4, p2 denotes 0, 1, 2 or 3 r2 denotes 1, 2 or 3, whereas p2+r2≤4. 3. Liquid-crystalline medium according to claim 2 wherein the compound of the formula I is selected from the following group of compounds of the formula I-A to I-H, in which R a denotes and R 1 denotes H, an alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH 2 groups in these radicals may each be replaced, independently of one another, by —CH═CH—, —C≡C—, —CH═CH—, —O—, —CO—O—, —O—CO— in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen, R 2 denotes an alkyl radical having 1 to 8 C atoms, L 1 and L 2 in each case, independently of one another, denotes F, Cl, Br, I, —CN, —NO 2 , —NCO, —NCS, —OCN, —SCN, straight-chain alkyl having 1 to 5 C atoms, branched alkyl having 3 to 5 C atoms, alkoxy having 1 to 5 C atoms, alkylcarbonyl having 2 to 5 C atoms, alkoxycarbonyl having 2 to 5 C atoms, alkylcarbonyloxy having 2 to 5 C atoms or alkoxycarbonyloxy having 2 to 5 C atoms, in which, in addition, one or more H atoms may be replaced by F or Cl, m denotes 0, 1 or 2, P denotes a polymerisable group, Sp denotes a spacer group or a single bond, and Z 1 and Z 2 in each case, independently of one another, denotes a single bond, —O—, —S—, —CO—, —CO—O—, —OCO—, —O—CO—O—, —OCH 2 —, —CH 2 —, —CH 2 O—, —CF 2 O—, —OCF 2 —, —CH 2 CH 2 —, —(CH 2 ) 4 —, —CF 2 CH 2 —, —CH 2 CF 2 —, —CF 2 CF 2 —, —CH═CH—, —CF═CF—, —C≡C—, —CH═CH—COO— or —OCO—CH═CH—, L 3 in each case, independently of one another, denotes Cl, Br, I, —CN, —NO 2 , —NCO, —NCS, —OCN, —SCN, straight-chain alkyl having 1 to 5 C atoms, branched alkyl having 3 to 5 C atoms, alkoxy having 1 to 5 C atoms, alkylcarbonyl having 2 to 5 C atoms, alkoxycarbonyl having 2 to 5 C atoms, alkylcarbonyloxy having 2 to 5 C atoms or alkoxycarbonyloxy having 2 to 5 C atoms, in which, in addition, one or more H atoms may be replaced by F or Cl, r1 denotes 0, 1, 2 or 3, whereas p1+r1≤4, r2 denotes 1, 2 or 3, whereas p2+r2≤4. 4. Liquid-crystalline medium according to claim 1 wherein the medium contains at least one compound selected from the following group of compounds of the formula I-1 to I-79

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11214736B2 cover?
Compounds of the formula I, liquid-crystalline media which contain at least one compound of the formula I and electro-optical displays which contain the LC mixtures, especially for the self-aligning VA, PSA, PS-VA, PVA, MVA, PM-VA, HT-VA or VA-IPS modein which R1, R2, ring A1, Z1, Z2, Sp, P, L1, L2, r1, r2, r3, m, n, p1 and p2 have the meanings indicated above.
Who is the assignee on this patent?
Merck Patent Gmbh
What technology area does this patent fall under?
Primary CPC classification C09K19/46. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).